KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Work In Process (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Work In Process data on record, last reported at $46.0 million in Q4 2025.

  • For Q4 2025, Work In Process changed 0.0% year-over-year to $46.0 million; the TTM value through Dec 2025 reached $46.0 million, changed 0.0%, while the annual FY2025 figure was $46.0 million, 0.0% changed from the prior year.
  • Work In Process reached $46.0 million in Q4 2025 per CL's latest filing, roughly flat from $46.0 million in the prior quarter.
  • Across five years, Work In Process topped out at $48.0 million in Q4 2022 and bottomed at $39.0 million in Q4 2021.
  • Average Work In Process over 5 years is $45.0 million, with a median of $46.0 million recorded in 2023.
  • Peak YoY movement for Work In Process: decreased 13.33% in 2021, then rose 23.08% in 2022.
  • A 5-year view of Work In Process shows it stood at $39.0 million in 2021, then rose by 23.08% to $48.0 million in 2022, then dropped by 4.17% to $46.0 million in 2023, then changed by 0.0% to $46.0 million in 2024, then changed by 0.0% to $46.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $46.0 million in Q4 2025, $46.0 million in Q4 2024, and $46.0 million in Q4 2023.